Neuropathic Pain Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuropathic Pain stocks.

Recent Signals

Date Stock Signal Type
2021-04-14 ASRT New Downtrend Bearish
2021-04-14 BIIB 200 DMA Resistance Bearish
2021-04-14 BIIB 180 Bearish Setup Bearish Swing Setup
2021-04-14 BLRX MACD Bearish Signal Line Cross Bearish
2021-04-14 CNCE Slingshot Bearish Bearish Swing Setup
2021-04-14 NKTR 200 DMA Resistance Bearish
2021-04-14 NKTR Pocket Pivot Bullish Swing Setup
2021-04-14 PSTI New 52 Week Closing Low Bearish
2021-04-14 PSTI Stochastic Reached Oversold Weakness
2021-04-14 RVNC Shooting Star Candlestick Bearish
2021-04-14 RVNC Crossed Above 20 DMA Bullish
2021-04-14 RVNC Lizard Bearish Bearish Day Trade Setup
2021-04-14 RVNC Bollinger Band Squeeze Range Contraction
2021-04-14 RVNC MACD Bullish Signal Line Cross Bullish
2021-04-14 RVNC Pocket Pivot Bullish Swing Setup
2021-04-14 XENE MACD Bullish Centerline Cross Bullish
2021-04-14 XENE MACD Bullish Signal Line Cross Bullish
2021-04-14 XENE Pocket Pivot Bullish Swing Setup
2021-04-14 ZYNE Pocket Pivot Bullish Swing Setup

Recent News for Neuropathic Pain Stocks

Date Stock Title
Apr 14 BIIB Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021
Apr 14 PSTI Cathie Wood Furthers Bet On Virgin Galactic, Also Adds DraftKings, Atlassian, Peloton
Apr 13 BIIB Sage (SAGE), Biogen Report Positive Data on Essential Tremor Study
Apr 13 ZYNE Zynerba: Repeated Trial Failures, Some Post Hoc Success
Apr 13 GWPH JAZZ's Xywav sNDA for Hypersomnia Gets FDA Priority Review
Apr 13 XENE How Many Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Do Institutions Own?
Apr 13 GWPH GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting
Apr 12 RVNC Revance signs supply agreement with contract manufacturer Lyophilization
Apr 12 BIIB Neurology Drug Study Does Little for Sage Therapeutics, or Its Partner Biogen
Apr 12 BIIB Biogen and Sage trade lower despite positive essential tremor trial
Apr 12 BIIB Sage-Biogen Essential Tremor Candidate Hits Primary Endpoint Goal, But 38% Of People Drop Out
Apr 12 BIIB Sage Stock Trips As Analysts Question Longevity Of Biogen-Partnered Drug
Apr 12 BIIB Sage Therapeutics/Biogen's SAGE-324 meets primary endpoint in essential tremor study
Apr 12 BIIB Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
Apr 12 PSTI Docusign, LendingTree, And Velo3D's Rumored SPAC — What Cathie Wood's Ark Bought And Sold On Friday
Apr 11 GWPH Healthcare Investors: Here's What You Need to Know About Medical Marijuana
Apr 10 RVNC The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 9 GWPH Jazz Securities Designated Activity Company -- Moody's assigns Ba2 to Jazz Pharma's new secured credit facilities; negative outlook
Apr 9 BIIB Biogen Announces Two New Nominees for Election to Board of Directors
Apr 9 NKTR Sanofi confirms partial response for cancer therapy in mid-stage study